| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
9,850,000 |
shares |
0% |
Q3 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Valuation Allowance |
$8,031 |
USD |
-78% |
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$8,031 |
USD |
-78% |
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2024 |
FY 2024 |
| Additional Paid in Capital |
$178,395 |
USD |
0% |
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |